We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Protein Droplets Stimulate Neurodegenerative Fibril Clumping

By LabMedica International staff writers
Posted on 03 May 2018
A team of neurodegenerative disease researchers has identified a molecular mechanism that prevents or reverses the formation of insoluble protein aggregates that characterize several brain disorders, including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS).

Members of the class of RNA-binding proteins (RBPs) with prion-like domains (PrLDs) experience a phase transition to a functional liquid form. More...
In this form, RBPs can mature into abnormal hydrogels composed of pathological fibrils that underpin fatal neurodegenerative disorders. Furthermore, several nuclear RBPs with PrLDs, including TDP-43, FUS, hnRNPA1, and hnRNPA2, mistakenly associate with cytoplasmic inclusions in neurodegenerative disorders, and mutations in their PrLDs can accelerate fibril formation and cause disease.

Investigators at the University of Pennsylvania (Philadelphia, USA) investigated the role of RBPs in the neurodegenerative disease process. They reported in the April 19, 2018, online edition of the journal Cell that nuclear-import receptors (NIRs) specifically chaperoned and potently disaggregated wild-type and disease-linked RBPs bearing a nuclear-localization sequence (NLS). A nuclear localization sequence is an amino acid signal that "tags" a protein for import into the cell nucleus by nuclear transport.

The investigators added NIRs to aggregates of TDP-43 and FUS proteins. They found that by increasing the concentration of NIRs in vitro, clumps of RBPs quickly dissolved. NIRs also dissolved cytoplasmic clumps in cells, and functional RBPs were returned to the nucleus. In addition, when the expression of NIRs was increased in fruit fly disease models, lifespan of the insects was extended and degeneration was reduced.

“Clumps that form from these disease proteins are composed of sticky fibrils that damage nerve cells,” said senior author Dr. James Shorter, associate professor of biochemistry and biophysics at the University of Pennsylvania. “We want to reverse the formation of these clumps and put the RNA-binding proteins back in their proper place, inside the nucleus.”

Related Links:
University of Pennsylvania


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.